Odyssey Health (ODYY) Free Cash Flow Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Free Cash Flow Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 29.64% |
| Jan 31, 2026 | 1.78% |
| Oct 31, 2025 | 1.32% |
| Jul 31, 2025 | 31.02% |
| Apr 30, 2025 | 31.29% |
| Jan 31, 2025 | 14.06% |
| Oct 31, 2024 | -2.96% |
| Jul 31, 2024 | -2.33% |
| Apr 30, 2024 | -44.38% |
| Jan 31, 2024 | -374.83% |
| Oct 31, 2023 | -26.65% |
| Jul 31, 2023 | -19.09% |
| Apr 30, 2023 | -123.22% |
| Jan 31, 2023 | -71.25% |
| Oct 31, 2022 | -56.03% |
| Jul 31, 2022 | 98.90% |
| Apr 30, 2022 | -59.06% |
| Jan 31, 2022 | -92.22% |
| Oct 31, 2021 | -275.01% |
| Jul 31, 2021 | -137.59% |